Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
150 USD | +0.31% | +1.00% | -1.32% |
May. 07 | Keefe Bruyette & Woods Adjusts Price Target on D.R. Horton to $178 From $172 | MT |
May. 06 | D R Horton Insider Sold Shares Worth $301,400, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on DR Horton
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering DR Horton
Keefe, Bruyette & Woods | |
Argus | |
Raymond James | |
JPMorgan Chase | |
UBS | |
Jefferies & Co. | |
BTIG | |
Goldman Sachs | |
Evercore ISI | |
Barclays | |
RBC Capital Markets | |
Zelman & Associates | |
Citigroup | |
Wedbush | |
JMP Securities | |
Seaport Global Securities | |
BofA Securities | |
Deutsche Bank Securities | |
Morningstar | |
Credit Suisse | |
Wolfe Research | |
KeyBanc Capital Markets | |
Wells Fargo Securities | |
Janney Capital | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- DHI Stock
- Consensus DR Horton